Intraperitoneal NMN-administered HFD-fed mice showed restored hepatic NAD+ levels, increased insulin secretion, and ameliorated impaired glucose tolerance (Supplementary Fig. 2a–c), as reported before16. Here, INS is linked to Impaired glucose tolerance.